Retatrutide, by Soma Chems , is attracting increasing attention as a potential treatment for metabolic control . This unique compound integrates the mechanism of a GLP-1 receptor stimulant and a GIP receptor agonist , intended to not only promote metabolic improvements but also address related metabolic conditions . Early human data have shown prom